AVP Receptor V1a Antibodies

Santa Cruz Biotechnology provides a broad selection of AVP Receptor V1a monoclonal antibodies for research focused on understanding this critical receptor. AVP Receptor V1a Antibodies are validated for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AVP Receptor V1a, also known as the vasopressin receptor 1A, plays a significant role in regulating vascular smooth muscle contraction and blood pressure, while also influencing social behaviors and stress responses. AVP Receptor V1a is extensively studied in cardiovascular research due to its crucial role in maintaining blood pressure homeostasis. Research has shown that AVP Receptor V1a signaling pathways are involved in numerous physiological processes, from water retention to emotional regulation. Understanding AVP Receptor V1a function has implications for developing treatments for conditions such as hypertension, anxiety disorders, and social behavior abnormalities. Investigating AVP Receptor V1a expression patterns helps reveal its distribution across different tissues and cell types, providing insights into its diverse biological functions. Santa Cruz Biotechnology monoclonal antibodies targeting AVP Receptor V1a enable researchers worldwide to advance our understanding of cardiovascular health and neurobiological processes.